Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 21, Number 11—November 2015

Histoplasmosis in HIV-Infected Persons, Yaoundé, Cameroon

Cite This Article

To the Editor: In HIV-infected persons in Cameroon (Central Africa), histoplasmosis is still misdiagnosed as tuberculosis because of clinical similarities (1,2). These patients are automatically given presumptive antituberculous therapy, although tuberculosis is not confirmed. The patients subsequently die of probable disseminated histoplasmosis (DH), and the fungal infection might finally be detected in postmortem tissue samples (3). In this context, 3 cases of DH were detected in HIV-infected patients within a 1-year period (2007–2008) in Yaoundé, Cameroon. We initiated this study to investigate the occurrence of histoplasmosis in HIV-infected patients in 4 medical centers for AIDS treatment in Yaoundé from December 2008 through December 2011.

We recruited patients with known HIV status who agreed to participate in the study. Inclusion criteria were CD4 cells <200/mm3, fever and cough of >2 weeks’ duration, weight loss, asthenia, and histoplasmosis-like skin manifestations (i.e., ulcerative lesions and/or umbilicated papules or nodules and/or pustules). Patients under effective antituberculous therapy or antimicrobial drugs for any skin or pulmonary infectious disease were excluded from the study. CD4 cell counts were performed in all patients. Histoplasmosis was diagnosed in sputum, bronchoalveolar fluid (BALF), and bronchial and skin biopsies by direct staining with Gomori’s methenamine silver and periodic acid Schiff stains and by culture of sputum and BALF samples on Sabouraud medium. Tuberculosis and bacterial infections were detected in sputum and BALF by using Ziehl-Neelsen and Gram staining and culture on Lowenstein-Jensen and Streptococcus pyogenes media. All laboratory examinations were performed at the Centre Pasteur du Cameroun in Yaoundé. Data were collected on an anonymous questionnaire. Means (and SDs) were calculated for quantitative variables, and frequencies were calculated for qualitative variables. The National Ethics Committee, the Ministry of Health of Cameroon, and the medical centers where the study took place approved the study. Patients approved and signed the informed consent form at the time of recruitment.

Our study comprised 56 patients. Histoplasma capsulatum was detected in 7 (13%) patients on 6 of 7 skin biopsies and 1 of 3 bronchial biopsies. The median CD4 cell count of H. capsulatum–positive patients was 40 cells/mm3. Similarly, some authors have reported diagnosis of severe DH by using direct staining of skin samples (4); in low-income countries, skin involvement is the main presentation of DH because of limited laboratory facilities and/or late diagnosis. In Cameroon until recently, all DH cases in HIV-infected persons were diagnosed by skin biopsy or by chance on peripheral blood smear, thus revealing AIDS at the terminal stage (3,5). We did not detect H. capsulatum infection in sputum or BALF. These results are congruent with findings in Abidjan, Côte d’Ivoire, in 1999 (6). African histoplasmosis was not detected in any sample; although this type is endemic to areas with high rates of HIV infection, it is infrequently associated with AIDS patients (7).

We detected Mycobacterium tuberculosis in 18 (32%) patients and Candida albicans in 14 (25%) patients; 3 (0.5%) patients were co-infected with M. tuberculosis and C. albicans. M. tuberculosis was detected in sputum of 9 (21%) of 42 patients and in BALF of 9 (53%) of 17 patients; we detected C. albicans in sputum of 13 (31%) patients. Our detection of M. tuberculosis in 32% of patients confirms tuberculosis as the main AIDS-defining illness in Cameroon. We did not find tuberculosis and histoplasmosis co-infection, even though it occurs frequently in low-income countries (1,8).

The limitation in our study was the unavailability of validated sensitive and specific tools for diagnosing histoplasmosis in Cameroon (e.g., detection of the H. capsulatum circulating antigen in body fluid using an enzyme immunoassay) (9). Thus, using direct staining methods and culture of biopsies and body fluid samples could possibly lead to false-negative results.

Our detection of H. capsulatum in 13% of the HIV-infected patients in this study suggests that histoplasmosis is an unknown public health problem in Cameroon that is misdiagnosed as tuberculosis. Accounting for the endemicity of tuberculosis, which is the main HIV-defining illness in Cameroon, and the fatal outcome of DH in HIV-infected patients, practitioners need a high index of awareness to differentiate between tuberculosis and histoplasmosis. A recent report showed major clinical and biologic factors discriminating between these infections (10). Knowing these factors may lead practitioners to early diagnosis and treatment of histoplasmosis and in turn reduce the death rate among HIV-infected patients.



We thank Omer Njajou for statistical analysis of data.

This study was financially supported by the Réseau International des Instituts Pasteur.


Christine E. MandengueComments to Author , Antoinette Ngandjio, and Paul J.A. Atangana
Author affiliations: Université des Montagnes, Bangangté, Cameroon (C.E. Mandengue); Centre Pasteur du Cameroun, Yaoundé, Cameroon (A. Ngandjio, P.J.A. Atangana)



  1. Couppié  P, Aznar  C, Carme  B, Nacher  M. American histoplasmosis in developing countries with a special focus on patients with HIV: diagnosis, treatment, and prognosis. Curr Opin Infect Dis. 2006;19:4439 . DOIPubMedGoogle Scholar
  2. Jeong  HW, Sohn  JW, Kim  MJ, Choi  JW, Kim  CH, Choi  SH, Disseminated histoplasmosis and tuberculosis in a patient with HIV infection. Yonsei Med J. 2007;48:5314. DOIPubMedGoogle Scholar
  3. Mandengue  CE, Lindou  J, Mandeng  N, Takuefou  B, Nouedoui  C, Atangana  P, Fatal miliary tuberculosis in an HIV-infected Cameroon woman: disseminated histoplasmosis due to Histoplasma capsulatum capsulatum [in French]. Med Trop (Mars). 2011;71:6157 .PubMedGoogle Scholar
  4. Couppié  P, Clyti  E, Nacher  M, Aznar  C, Sainte-Marie  D, Carme  B, Acquired immunodeficiency syndrome–related oral/or cutaneous histoplasmosis. a descriptive study of 21 cases in French Guiana. Int J Dermatol. 2002;41:5716. DOIPubMedGoogle Scholar
  5. Mandengue Ebenye  C. A case of disseminated histoplasmosis detected in peripheral blood smear staining revealing AIDS at terminal phase in female patient from Cameroon. Case Rep Med. 2012;2012:215207.
  6. Adou-Bryn  KD, Ouhon  J, Assoumou  A, Kassi  EA, Kone  M, Therizol-Ferly  M. Champignons et parasites isolés à l’examen de 142 liquides d’aspiration bronchique à Abidjan (Côte d’Ivoire). Med Afr Noire. 1999;46:3625.
  7. Loulergue  P, Bastides  F, Baudouin  V, Chandenier  J, Mariani-Kurkdjian  P, Dupont  B, Literature review and case histories of Histoplasma capsulatum var. duboisii infections in HIV-infected patients. Emerg Infect Dis. 2007;13:164752. DOIPubMedGoogle Scholar
  8. Agudelo  CA, Carlos  A, Restrepo  CA, Molina  DA, Tobón  AM, Kauffman  CA, Tuberculosis and histoplasmosis co-infection in AIDS patients. Am J Trop Med Hyg. 2012;87:10948. DOIPubMedGoogle Scholar
  9. Adenis  AA, Aznar  C, Couppié  P. Histoplasmosis in HIV-infected patients: a review of new developments and remaining gaps. Curr Trop Med Rep. 2014;1:119–28.
  10. Adenis  A, Nacher  M, Hanf  M, Basurko  C, Dufour  J, Huber  F, Tuberculosis and histoplasmosis among human immunodeficiency virus–infected patients: a comparative study. Am J Trop Med Hyg. 2014;90:21623 . DOIPubMedGoogle Scholar


Cite This Article

DOI: 10.3201/eid2111.150278

Related Links


Table of Contents – Volume 21, Number 11—November 2015

EID Search Options
presentation_01 Advanced Article Search – Search articles by author and/or keyword.
presentation_01 Articles by Country Search – Search articles by the topic country.
presentation_01 Article Type Search – Search articles by article type and issue.



Please use the form below to submit correspondence to the authors or contact them at the following address:

Christine E. Mandengue, Department of Internal Medicine (Dermatology), Université des Montagnes, Cliniques Universitaires des Montagnes, PO Box 208, Bangangté, Cameroon

Send To

10000 character(s) remaining.


Page created: October 19, 2015
Page updated: October 19, 2015
Page reviewed: October 19, 2015
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.